Generated by AI
Compass Pathways plc - ADR is a clinical-stage biotechnology company focused on mental health care. Compass Pathways develops COMP360, a proprietary synthetic psilocybin therapy being studied for treatment-resistant depression and other psychiatric conditions, including post-traumatic stress disorder and anorexia nervosa. The company’s work centers on evidence-based psychedelic medicine, combining drug development with psychotherapy-oriented treatment models. Based in London, Compass Pathways operates across the United Kingdom and the United States and serves as a specialist participant in the emerging mental health therapeutics market. Its current business is centered on advancing investigational treatments through clinical trials and preparing for broader medical use if approved.
Website33 Broadwick Street
London, W1F 0DQ
United Kingdom
The latest articles about CMPS.
Summary of Nov 18's posts. Generated by AI.
Summary of Nov 18's posts. Generated by AI.
Summary of Jul 16's posts. Generated by AI.
Summary of Nov 16's posts. Generated by AI.
Investors talking about CMPS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.